News & Analysis on Clinical Trial Services & Contract Research And Development
US-based researchers have proven that 'large' nanoparticles can pass through human mucus, which means that they could serve as sustained-release carriers for drugs treating diseases affecting the mucous membranes, such as cervical cancer.
The move towards electronic files is set to bring major benefits in the clinical trials area especially in terms of patient recruitment, new research suggests.
Pfizer has announced it will axe 10,000 jobs and close facilities in a further effort to save on costs; the move comes in the face of patent expiries for their biggest drugs and the failure of a late-stage pipeline project.
Novel transdermal patch products for two protein drugs could be on the horizon as Altea Therapeutics announces research agreements with two 'large' pharmaceutical companies.
There are currently three key market trends that play to Parexel's strengths and one of them is the globalisation of clinical trials, the company's CEO claimed during a healthcare conference earlier this month.
German fine chemicals company Saltigo is benefiting from a cash injection from its parent company, Lanxess. The German firm is earmarking €30m for plant modernisation at its subsidiary, and a €10m brand new multi-purpose facility is already under...
Evotec has inked two new deals with Solvay to provide fragment-based and library synthesis drug discovery services.
Rexam has introduced two new desiccant caps - Evipharm & Secupharm - that use a filled in-line silica gel as a desiccant to improve shelf life of the drug.